HIV infection

Treatment Phase: Initial

Clinical criteria:

  • Patient must be antiretroviral treatment naive,

AND

  • The treatment must be in combination with other antiretroviral agents.

Note

Pharmaceutical benefits that have the form atazanavir 300 mg capsule, 30 and pharmaceutical benefits that have the form atazanavir 300 mg capsule, 60 are equivalent for the purposes of substitution.

HIV infection

Treatment Phase: Continuing

Clinical criteria:

  • Patient must have previously received PBS-subsidised therapy for HIV infection,

AND

  • The treatment must be in combination with other antiretroviral agents.

Note

Pharmaceutical benefits that have the form atazanavir 300 mg capsule, 30 and pharmaceutical benefits that have the form atazanavir 300 mg capsule, 60 are equivalent for the purposes of substitution.